Exome Asset Management »

Ideaya Biosciences shares owned by Exome Asset Management

Quarter-by-quarter ownership of Ideaya Biosciences shares owned by Exome Asset Management from 13F filings

Historical chart of Exome Asset Management investment in Ideaya Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Ideaya Biosciences held by Exome Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ideaya Biosciences by Exome Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.7M 80k 33.32

More positions owned by Exome Asset Management

Praxis Precision Medicines I Com New (PRAX)
Cogent Biosciences (COGT)
Enliven Therapeutics (ELVN)
Ionis Pharmaceuticals (IONS)
Spdr Series Trust State Street Spd Put Option (XBI)
Guardant Health (GH)
Cytokinetics Com New (CYTK)
Eli Lilly & Co. (LLY)
Alumis (ALMS)
Bridgebio Pharma (BBIO)
Vera Therapeutics Cl A (VERA)
Insmed Com Par $.01 (INSM)
Anthem (ELV)
Agios Pharmaceuticals (AGIO)
United Therapeutics Corporation (UTHR)

View all positions for Exome Asset Management

Top funds holding Ideaya Biosciences

Exome Asset Management
Simplex Trading
Group One Trading

View all funds holding Ideaya Biosciences